Literature DB >> 2203264

Prolonged ambulatory esophageal pH monitoring in the evaluation of gastroesophageal reflux disease.

H E Mattox1, J E Richter.   

Abstract

Gastroesophageal reflux disease is a common problem that frequently presents with atypical complaints including nausea, hiccups, globus sensation, chest pain, hoarseness, coughing, or various pulmonary complaints. Diagnosis may be difficult, as these patients often do not have radiographic or endoscopic evidence of esophagitis. In these difficult cases, prolonged esophageal pH monitoring provides an accurate method of quantitating acid reflux parameters and correlating symptoms with reflux episodes in an outpatient setting. Current equipment is compact, durable, and not difficult to use or extremely expensive. Data analysis, with a particular emphasis on acid-exposure time (total, upright, supine), reliably discriminates between abnormal and normal subjects but it is not a perfect "gold standard" for gastroesophageal reflux disease. Indications for esophageal pH monitoring include: (1) atypical symptoms of acid reflux with normal endoscopy, (2) typical reflux symptoms unresponsive to medical therapy, and (3) the follow-up of reflux disease after either medical or surgical therapy. This test is currently performed primarily by gastroenterologists, but we believe many other groups may find this technology helpful. To meet these expanding applications, test refinements are necessary, particularly easier methods of placing the pH probe and better standards for defining abnormal pH parameters in older patients. The future for esophageal pH monitoring is bright. This technology has the potential to do for the diagnosis of gastroesophageal reflux disease what endoscopy has done for the diagnosis of peptic ulcer disease.

Entities:  

Mesh:

Year:  1990        PMID: 2203264     DOI: 10.1016/0002-9343(90)90348-h

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  18 in total

1.  Functional Gastroesophageal Reflux Disease (GERD).

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-08

2.  Esophageal dysmotility and gastroesophageal reflux in intrinsic asthma.

Authors:  S Campo; S Morini; M A Re; D Monno; R Lorenzetti; B Moscatelli; E Bologna
Journal:  Dig Dis Sci       Date:  1997-06       Impact factor: 3.199

3.  Barium study associated with water siphon test in gastroesophageal reflux disease and its complications.

Authors:  E Fiorentino; F Barbiera; D Cabibi; G Pantuso; S Bonventre; A Aiello; S Latteri; T D'Agostino
Journal:  Radiol Med       Date:  2007-09-20       Impact factor: 3.469

Review 4.  Diagnosis of reflux disease.

Authors:  N I McDougall
Journal:  Ir J Med Sci       Date:  1996 Jul-Sep       Impact factor: 1.568

5.  Impact of ingested liquids on 24-hour ambulatory pH tests.

Authors:  J P Shoenut; D Duerksen; C S Yaffe
Journal:  Dig Dis Sci       Date:  1998-04       Impact factor: 3.199

6.  Selective-serotonin reuptake inhibitors for the treatment of hypersensitive esophagus.

Authors:  Nikos Viazis; George Karamanolis; Eleni Vienna; Dimitrios G Karamanolis
Journal:  Therap Adv Gastroenterol       Date:  2011-09       Impact factor: 4.409

7.  Prolonged intraesophageal pH monitoring with 16-hr overnight recording. Comparison with "24-hr" analysis.

Authors:  R Dobhan; D O Castell
Journal:  Dig Dis Sci       Date:  1992-06       Impact factor: 3.199

8.  Relationship between acid reflux episodes and gastroesophageal reflux symptoms is very inconstant.

Authors:  E Colas-Atger; B Bonaz; E Papillon; N Gueddah; A Rolachon; R Bost; J Fournet
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

9.  Effect of ambulatory 24-hour esophageal pH monitoring on reflux-provoking activities.

Authors:  R Fass; R Hell; R E Sampliner; G Pulliam; E Graver; V Hartz; C Johnson; P Jaffe
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

10.  Effects of omeprazole versus placebo in treatment of noncardiac chest pain and gastroesophageal reflux.

Authors:  S R Achem; B E Kolts; T MacMath; J Richter; D Mohr; L Burton; D O Castell
Journal:  Dig Dis Sci       Date:  1997-10       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.